8-Hydroxydeoxyguanosine: A new potential independent prognostic factor in breast cancer

British Journal of Cancer

Volumn 102, Issue 6, 2010, Pages 1018-1023

  Sova, H ^a   Jukkola Vuorinen, A ^a   Puistola, U ^a   Kauppila, S ^a   Karihtala, P ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

8 oxodG; DNA repair; Immunohistochemistry; Oxidative stress; Reactive oxygen species

Indexed keywords

8 HYDROXYDEOXYGUANOSINE;

ARTICLE; BLOOD LEVEL; BREAST CANCER; BREAST CARCINOMA; BREAST DUCT; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DEOXYGUANOSINE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77949542434     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605565     Document Type: Article

References (39)

1. Barnes DM, Camplejohn RS (1996) P53, apoptosis, and breast cancer. J Mammary Gland Biol Neoplasia 1: 163-175
2. Cho SH, Choi MH, Lee WY, Chung BC (2009) Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal. Clin Biochem 42: 540-543
3. Cooke MS, Evans MD, Dove R, Rozalski R, Gackowski D, Siomek A, Lunec J, Olinski R (2005) DNA repair is responsible for the presence of oxidatively damaged DNA lesions in urine. Mutat Res 574: 58-66
4. Cooke MS, Loft S, Olinski R (2008) Measurement and meaning of oxidatively modified DNA lesions in urine. CEBP 17: 3-14
5. Cooke MS, Olinski R, Evans MD (2006) Does measurement of oxidative damage to DNA have clinical significance? Clin Chim Acta 365: 30-49
6. Dincer Y, Himmetoglu S, Akcay T, Ersoy EY, Gunes KN, Tortum O (2007) Prognostic significances of oxidative DNA damage evaluated by 8-hydroxy-deoxyguanosine and antioxidant enzymes in patients undergoing resection of gastric and colon carcinoma. Neoplasma 54: 131-136
7. Evans MD, Cooke MS (2006) Oxidative damage to DNA in non-malignant disease: biomarker or biohazard? Genome Dyn 1: 53-66
8. Farinati F, Cardin R, Bortolami M, Nitti D, Basso D, de Bernard M, Cassaro M, Sergio A, Rugge M (2008) Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphism. Int J Cancer 1: 51-55
9. Hirano T (2008) Repair system of 7, 8-dihydro-8-oxoguanine as a defense line against carcinogenesis. J Radiat Res 49: 329-340
10. Hussain SP, Raja K, Amstad PA, Sawyer M, Trudel LJ, Wogan GN, Hofseth LJ, Shields PG, Billiar TR, Trautwein C, Hohler T, Galle PR, Phillips DH, Markin R, Marrogi AJ, Harris CC (2000) Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases. Proc Natl Acad Sci USA 97: 12770-12775
11. Jaruga P, ñski R, Biczysko W, Szyfter W, Nagy E, Möller L, Szyfter K (2003) Oxidative DNA base modifications and polycyclic aromatic hydrocarbon DNA adducts in squamous cell carcinoma of the larynx. Free Radical Res 37: 231-240
12. Kaczmarek P, strok;aszczyk J, ałkowski P, rakowska-Fijałek A, Niemirowicz J, Kasprzak A, Baj Z (2005) Assessment of 8-hydroxy-2- deoxyguanosine concentrations in bladder cancer patients treated with intravesical BCG instillation. Pol Merkur Lekarski 19: 526-528
13. Karihtala P, Mäntyniemi A, Kang SW, Kinnula VL, Soini Y (2003) Peroxi-redoxins in breast carcinoma. Clin Cancer Res 9: 3418-3424
14. Karihtala P, Soini Y (2007) Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. APMIS 115: 81-103
15. Kuo HW, Chou SY, Hu TW, Wu FY, Chen DJ (2007) Urinary 8-hydroxy-2-deoxyguanosine (oxodG) and genetic polymorphisms in breast cancer patients. Mutat Res 631: 62-68
16. Lau A, Villeneuve NF, Sun Z, Wong PK, Zhang DD (2008) Dual roles of Nrf2 in cancer. Pharmacol Res 58: 262-270
17. Lee BM, Jang JJ, Kim HS (1998) Benzo[a]pyrene diolepoxide-I-DNA and oxidative DNA adducts associated with gastric adenocarcinoma. Cancer Lett 125: 61-68
18. Loft S, Poulsen HE (1996) Cancer risk and oxidative DNA damage in man. J Mol Med 74: 297-312
19. Matsui A, Ikeda T, Enomoto K, Hosoda K, Nakashima H, Omae K, Watanabe M, Hibi T, Kitajima M (2000) Increased formation of oxidative DNA damage, 8-hydroxy-2-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett 51: 87-95
20. Matsumoto K, Satoh Y, Sugo H, Takamori S, Kojima K, Fukasawa M, Beppu T, Futagawa S (2003) Immunohistochemical study of the relationship between 8-hydroxy-2-deoxyguanosine levels in noncancerous region and postoperative recurrence of hepatocellular carcinoma in remnant liver. Hepatol Res 25: 435-441
21. Miyake H, Hara I, Kamidono S, Eto H (2004) OxidativeDNA damage in patients with prostate cancer and its response to treatment. J Urol 171: 1533-1536
22. Nagashima M, Tsuda H, Takenoshita S, Nagamachi Y, Hirohashi S, Yokota J, Kasai H (1995) 8-Hydroxydeoxyguanosine levels in DNA of human breast cancer are not significantly different from those of non-cancerous breast tissues by the HPLC-ECD method. Cancer Lett 90: 157-162
23. Nishigori C, Arima Y, Matsumura Y, Matsui M, Miyachi Y (2005) Impaired removal of 8-hydroxydeoxyguanosine induced by UVB radiation in naevoid basal cell carcinoma syndrome cells. Br J Dermatol 153: 52-56
24. Okamoto K, Toyokuni S, Uchida K, Ogawa O, Takenewa J, Kakehi Y, Kinoshita H, Hattori-Nakakuki Y, Hiai H, Yoshida O (1994) Formation of 8-hydroxy-2-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma. Int J Cancer 58: 825-829
25. Oliva MR, Ripoll F, Muñiz P, Iradi A, Trullenque R, Valls V, Drehmer E, Sáez GT (1997) Genetic alterations and oxidative metabolism in sporadic colorectal tumors from a Spanish community. Mol Carcinog 18: 232-243
26. Paz-Elizur T, Ben-Yosef R, Elinger D, Vexler A, Krupsky M, Berrebi A, Shani A, Schechtman E, Freedman L, Livneh Z (2006) Reduced repair of the oxidative 8-oxoguanine DNA damage and risk of head and neck cancer. Cancer Res 66: 11683-11689
27. Paz-Elizur T, Krupsky M, Blumenstein S, Elinger D, Schechtman E, Livneh Z (2003) DNA repair activity for oxidative damage and risk of lung cancer. J. Natl Cancer Inst 95: 1312-1319
28. Peoples MC, Karnes HT (2005) Recent developments in analytical methodology for 8-hydroxy-2-deoxyguanosine and related compounds. J Chromatogr B Analyt Technol Biomed Life Sci 827: 5-15
29. Romano G, Sgambato A, Mancini R, Capelli G, Giovagnoli MR, Flamini G, Boninsegna A, Vecchione A, Cittadini A (2000) 8-Hydroxy-2-deoxy-guanosine in cervical cells: correlation with grade of dysplasia and human papillomavirus infection. Carcinogenesis 21: 1143-1147
30. Ross JS, Slodkowska EA, Symmans WF, Pusztai L, Ravdin PM, Hortobagyi GN (2009) The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine. Oncologist 14: 320-368
31. Shen J, Deininger P, Hunt JD, Zhao H (2007) 8-Hydroxy-2-deoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer. Cancer 109: 574-580
32. Singh A, Boldin-Adamsky S, Thimmulappa RK, Rath SK, Ashush H, Coulter J, Blackford A, Goodman SN, Bunz F, Watson WH, Gabrielson E, Feinstein E, Biswal S (2008) RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. Cancer Res 68: 7975-7984
33. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182
34. Sentürker S, Karahalil B, Inal M, Yilmaz H, Müslümanoglu H, Gedikoglu G, Dizdaroglu M (1997) Oxidative DNA base damage and antioxidant enzyme levels in childhood acute lymphoblastic leukemia. FEBS Lett 416: 286-290
35. Tavassoli FA, Devilee P (2003) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC Press: Lyon
36. Toyokuni S, Tanaka T, Hattori Y, Nishiyama Y, Yoshida A, Uchida K, Hiai H, Ochi H, Osawa T (1997) Quantitative immunohistochemical determination of 8-hydroxy-2-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 76: 365-374
37. Turunen N, Karihtala P, Mantyniemi A, Sormunen R, Holmgren A, Kinnula VL (2004) Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma. APMIS 112: 123-132
38. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J (2004) Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 266: 37-56
39. Vulimiri SV, Wu X, Baer-Dubowska W, Andrade Md, Detry M, Spitz MR, DiGiovanni J (2000) Analysis of aromatic DNA adducts and 7,8-dihydro-8-oxo-2 deoxyguanosine in lymphocyte DNA from a case-control study of lung cancer involving minority populations. Mol Carcinog 27: 34-46